Kar Fai Lam
ir.catalystpharma.com/news-releases/news-release-details/catalyst-pharmaceuticals-reports-preliminary-fourth-quarter-0 $CPRX 2022 Preliminary results : Revenue - 52% YoY growth
Not investment advice. The author may have financial interests in the mentioned instruments.
null
.